Meetings

Wales Life Science Investment Fund

This page gives details of any meetings held which will, or did, discuss the matter, and includes links to the relevant Papers, Agendas and Minutes.

Note: Meeting Agenda can change at short notice. Particularly where future meeting dates are indicated more than a week in advance. Please check before planning to attend a Committee Meeting that the item you are interested in has not been moved.

 

 

Meeting: 27/09/2023 - Public Accounts and Public Administration Committee (Item 3)

3 Life Sciences Investment Fund

Andrew Slade

Director General, Economy, Skills and Natural Resources Group

 

Duncan Hamer

Director Operations, Business and Regions

 

Giles Thorley

Chief Executive, Development Bank of Wales

 

Rob Hunter

Strategy, People and Development Director, Development Bank of Wales

 

Supporting paper

 

Background research brief

Briefing questions

Evidence paper from Welsh Government

Regeneris Review of Welsh Life Sciences Investment Fund

Supporting documents:

Minutes:

3.1 The Committee took evidence from the Welsh Government and the Development Bank of Wales as part of its inquiry into the Life Sciences Investment Fund.

Meeting: 15/03/2016 - Public Accounts Committee - Fourth Assembly (Item 7)

Wales Life Science Investment Fund: Consideration of the evidence received

Minutes:

7.1 Members discussed the evidence received at Committee on 8 March and agreed that the Chair would write to the Welsh Government seeking clarification on the evidence received at that meeting and this action will be noted in the Committee’s Legacy Report

Meeting: 15/03/2016 - Public Accounts Committee - Fourth Assembly (Item 2)

2 Wales Life Science Investment Fund: Letter from the Minister for Economy, Science and Transport (7 March 2016)

Supporting documents:

Meeting: 08/03/2016 - Public Accounts Committee - Fourth Assembly (Item 6)

Wales Life Science Investment Fund: Consideration of evidence received

Minutes:

6.1 Due to time constraints, Members agreed to consider the evidence received in the meeting scheduled for 15 March 2016.

Meeting: 08/03/2016 - Public Accounts Committee - Fourth Assembly (Item 4)

4 Wales Life Science Investment Fund

Research Briefing

 

James Price – Deputy Permanent Secretary - Economy, Skills and Natural Resources Group, Welsh Government

 

Gareth Bullock – Chair, Finance Wales plc

Supporting documents:

Minutes:

4.1 The Committee scrutinised James Price, Deputy Permanent Secretary, Economy, Skills and Natural Resources Group at the Welsh Government and Gareth Bullock, Chair, Finance Wales plc on Wales Life Science Investment Fund.

4.2 James Price agreed to:

·       Provide clarification of the selection panel’s composition, when the advisory panel appointments were made and the number of members appointed from outside Wales;

·       Raise within the Welsh Government, whether legal advice sought by the Welsh Government should be shared with arms-length bodies;

·       Confirm the level of grant funding offered to ReNeuron;

·       Clarify whether full minutes were taken at the WIDAB meetings of 18 June 2013 and 24 October 2013.  

4.3 Gareth Bullock agreed to provide further information regarding arrangement fees payable to Fund Managers from Investor Companies.

 

 

 

Meeting: 01/03/2016 - Public Accounts Committee - Fourth Assembly (Item 6)

6 Wales Life Science Investment Fund: Briefing from the Auditor General for Wales

PAC(4)-08-16 Paper 8 – Letter from the Chair to the Auditor General for Wales (24 November 2015)

PAC(4)-08-16 Paper 9 – Letter from the Auditor General for Wales to the Chair (7 November 2015)

 

Supporting documents:

Minutes:

6.1 Members received a briefing from the Auditor General for Wales on his report, Establishment and Oversight of the Wales Life Science Investment Fund, which was published on 26 February.

 

Topics

Helpful Links

Related